Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease that affects over 30% of the world ’s population. For decades, the heterogeneity of non-alcoholic f...

Source: Lipids in Health and Disease - April 2, 2024 Category: Lipidology Authors: Yuxiao Jiang, Lili Wu, Xiaopeng Zhu, Hua Bian, Xin Gao and Mingfeng Xia Tags: Review Source Type: research